3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
3
Phase NA
2
Phase 1/2
2
Phase EARLY_PHASE1
1
Phase 2
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
2
Head & Neck
2
Genitourinary
1
Gastrointestinal
1
CNS
1
Conditions
Prostatic Neoplasms
103
Carcinoma, Renal Cell
30
Urinary Bladder Neoplasms
22
Breast Neoplasms
20
Carcinoma, Transitional Cell
11
Lung Neoplasms
10
Melanoma
9
Neoplasms
8
Kidney Neoplasms
8
Neoplasm Metastasis
7
Colonic Neoplasms
7
Sarcoma
6
Pancreatic Neoplasms
6
Ovarian Neoplasms
6
Metastatic Castration-resistant Prostate Cancer
6
Head and Neck Neoplasms
5
Carcinoma, Non-Small-Cell Lung
5
Uterine Cervical Neoplasms
4
Stomach Neoplasms
4
Brain Neoplasms
4
Osteosarcoma
3
Diabetes Mellitus
3
Colorectal Neoplasms
3
Carcinoma, Squamous Cell
3
Carcinoma, Hepatocellular
3
Urologic Neoplasms
2
Squamous Cell Carcinoma of Head and Neck
2
Recurrence
2
Rectal Neoplasms
2
Prostatic Hyperplasia
2
Interventions
3-(4-(2-fluoroethoxy)phenyl)-2-(3-methyl-2-(4-((2-sulfamoylbenzo(d)thiazol-6-yloxy)methyl)-1H-1,2,3-triazol-1-yl)butanamido)propanoic acid
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase EARLY_PHASE1
×
Hypoxia
×
Genitourinary
×
Clear all
NCT00884520
2010-03-16
VM4-037
Siemens Molecular Imaging
Phase EARLY_PHASE1
Completed
16 enrolled